Leadership
Giulio F. Draetta, M.D., Ph.D.
Chief Scientific Officer
Sr. Vice President & Head, Therapeutics Discovery
Philip Jones, Ph.D.
Vice President, Therapeutics Discovery
Head of Drug Discovery
Platform Leadership
The Therapeutics Discovery division supports five research platforms.
ECLIPSE
-
Jeffrey Molldrem, M.D.
Professor, Stem Cell Transplantation and Cellular Therapy
Institute for Applied Cancer Science (IACS)
-
Philip Jones, Ph.D.
Head of Drug Discovery
Neurodegeneration Consortium (NDC)
-
Jim Ray, Ph.D.
Head, Neurodegeneration Research
ORBIT
-
Tim Heffernan, Ph.D.
Executive Director, Oncology Research
-
Jeffrey Molldrem, M.D.
Professor, Stem Cell Transplantation and Cellular Therapy
TRACTION
-
Tim Heffernan, Ph.D.
Executive Director, Oncology Research
-
Joseph Marszalek, Ph.D.
Co-leader, TRACTION
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.